Injective falls nearly 13% as technical pressures overshadow mainnet upgrade support
Injective (INJ) fell 12.85% after a sharp downward gap, with the move unfolding even as major protocol and ecosystem upgrades received strong community backing. The near-term decline is supported by technical downside pressure, as INJ trades below its 20-day and 50-day moving averages.
Highlights
- Injective received over 99% community approval to upgrade its Veyra mainnet, targeting institutional trading and real-world asset tokenization.
- More than $80 million in USDC stablecoin liquidity migrated on Cosmos, with updated protocols and new deposit options for dYdX users.
- INJ/USD trades below short- and medium-term averages with a 76% probability of downside in the next five sessions, projected between $6.03 and $7.81.
Staker optimism persists despite large liquidity migration and selloff
Injective received strong community approval for the Veyra mainnet upgrade, with over 99% of stakers voting in favor as of mid-November 2026. The upgrade is aimed at expanding institutional trading and real-world asset tokenization capabilities. Injective was also at the center of a major migration of over $80 million in USDC stablecoin liquidity within the Cosmos ecosystem, with new deposit routes and updated protocols announced for dYdX users, though price action has remained under broader selling pressure.
Mixed indicator signals as short-term pressure meets long-term support
INJ/USD is trading below both the 20-day and 50-day moving averages at $7.72 and $7.80, respectively, but remains above the 200-day average at $5.81. This configuration points to continued downside pressure in the short and medium term, while the alignment of the 50-day and 200-day averages confirms a longer-term bullish structure. Immediate resistance is located at $7.13, today’s high, and short-term support appears at $6.66, the weekly low. Technical indicators show mixed signals: MACD, ADX, RSI, and CCI are all neutral, Stochastic RSI is in the oversold zone, Bull/Bear Power is slightly positive at 0.5, and the Awesome Oscillator remains negative, highlighting the ongoing downside bias. INJ/USD last traded at $6.92, with intraday volatility recorded at 8.69%. Selling pressure has dominated the session following significant losses after the open.
Previously it was reported that Injective was experiencing persistent short- and medium-term price pressure despite robust governance activity and institutional developments around the Veyra upgrade. The current article reinforces this outlook, with continued technical headwinds dictating a broad sideways-to-lower trading scenario and $6.66 now emerging as the critical support level to watch for potential downside acceleration.